Search results
Added:
3 years ago
Over the past 40 years impressive progress has been made in treating focal, obstructive coronary artery disease (CAD) using percutaneous coronary interventions (PCI) and the most sophisticated surgical bypass techniques. Although women have profited to a great extent from these advancements, sex and gender differences in ischemic heart disease (IHD) are still under-recognised and even ignored…
View more
Added:
3 years ago
For decades, conventional wisdom suggested that sinus rhythm was preferred over rate control in the treatment of patients with atrial fibrillation (AF). Recent randomised trials have been unable to substantiate this viewpoint, and the occurrence of serious outcomes for patients has been similar for both treatment strategies.1,2
More specifically, several large, randomised, prospective clinical…
View more
Added:
11 months ago
ESC-HFA 2023 – Prof John Cleland (University of Glasgow, Glasgow, UK) discusses the findings from a study that looked at the diagnostic of heart failure in a cohort of 1.1 million people using the NHS EMR database.
Finding presented at Heart Failure 2023, showed that more people treated with LD than receive diagnosis of heart failure, this disparity was greater in women compared to men.
…
View more
Complex Heart Failure Case - Case Study
Video Series
Added:
3 years ago
Acute heart failure is usually defined as the rapid onset of, or change in, signs and/or symptoms of heart failure resulting in the need for urgent treatment.1 It can occur as the first manifestation of a failing heart (acute de novo heart failure) or it can occur in a patient with a chronic history of heart failure, in which case the term ‘acute decompensation’ is often applied.
The acute heart…
View more
Added:
1 year ago
Heart failure management: Where are we now?
Dip into the new heart failure data presented at ESC-HF Conference 2022. Learn more about the latest research and treatment options delivered by researchers driving the field.Short, accessibleExpert Interviewswill be available with select faculty focusing on the results, applicability, and impact on future research.
Join globally renown faculty as…
View more
Added:
3 years ago
Heart failure (HF) is currently achieving epidemic proportions, representing the single fastest-growing diagnosis among patients aged >65 years of age and the most common cause for hospitalisation in these patients.1 In addition to having a high incidence and prevalence, HF is associated with substandard clinical outcomes and with high rates of hospitalisation and death.1 Accordingly, great…
View more
Added:
3 years ago
Atrial fibrillation (AF) and heart failure (HF) are two disease conditions that are intimately intertwined, both pathophysiologically and clinically. Currently, over 2.3 million people in North America and 4.5 million in the EU have AF, making it the most common arrhythmia encountered in clinical practice.1,2 It is expected that by 2050 there will be over 10 million people with AF.3 The estimated…
View more
Added:
3 years ago
Advances in the treatment of complex congenital heart disease over the past 20 years have led to a dramatic improvement in long-term survival.1 However, the incidence of cardiac arrhythmias as a sequel of palliative heart surgery has also increased significantly in adolescent and adult survivors of congenital heart disease surgery.1,2 Cardiac arrhythmias are the leading cause of emergency…
View more
Added:
1 year ago
In this video series, first presented at the ESC Congress 2022, held in Barcelona, Prof Ralph Stephan von Bardeleben, Prof Jose LuisZamorano, Dr Victoria Delgado, Prof DavideCapodanno and Dr SashaKoul discuss the diagnosis of low flow/low gradient aortic stenosis, which patients gain the most benefit from TAVI and how to avoid heart failure in aortic stenosis patients. Join this international…
View more
« First